MicroCLOTS pathophysiology in coronavirus disease 2019

참고문헌 (10)

1. Toniati P, "Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure : a single center study of 100 patients in Brescia, Italy", Autoimmun Rev, 19, pp.102568~ (2020)
2. Ciceri F, "Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome(MicroCLOTS) : an atypical acute respiratory distress syndrome working hypothesis", Crit Care Resusc, 22, pp.95~97 (2020)
3. "Pulmonary post-mortem findings in a large series of COVID-19 cases from Northern Italy" (2020)[URL]
4. Wichmann D, "Autopsy findings and venous thromboembolism in patients with COVID-19 : a prospective cohort study", Ann Intern Med, 173, pp.268~277 (2020)
5. Tang N, "Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia", J Thromb Haemost, 18, pp.844~847 (2020)
6. Gavriilaki E, "Severe COVID-19 infection and thrombotic microangiopathy : success does not come easily", Br J Haematol, 189, pp.e227~e230 (2020)
7. Bikdeli B, "COVID-19 and thrombotic or thromboembolic disease : implications for prevention, antithrombotic therapy, and follow-up : JACC stateof-the-art review", J Am Coll Cardiol, 75, pp.2950~2973 (2020)
8. Canonico ME, "The tug-of-war between coagulopathy and anticoagulant agents in patients with COVID-19", Eur Heart J Cardiovasc Pharmacother, 6, pp.262~264 (2020)
9. Thachil J, "ISTH interim guidance on recognition and management of coagulopathy in COVID-19", J Thromb Haemost, 18, pp.1023~1026 (2020)
10. Klok FA, "Incidence of thrombotic complications in critically ill ICU patients with COVID-19", Thromb Res, 191, pp.145~147 (2020)

관련 논문AI추천